- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Gout
Total 630 results
-
NestléCompletedMild to Moderate Levels of StressSwitzerland
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
AcelRx Pharmaceuticals, Inc.CompletedAcute Moderate-to-severe PainUnited States
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
Al-Azhar UniversityEnrolling by invitationModerate and Severe Crowding in Lower Dental ArchEgypt
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
LG Life SciencesUnknownNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar RegionKorea, Republic of
-
PfizerTerminatedModerate-severe PainUnited States
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of PfizerUnknownModerate to Severe Active Axial SpondyloarthritisGermany
-
PfizerTerminatedModerate-severe PainUnited States
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingModerate to Severe AsthmaUnited States
-
Fresenius Kabi SwissBioSim GmbHCompletedModerate to Severe Rheumatoid ArthritisBulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
University of PadovaUnknownModerate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Italy
-
Ulthera, IncUniversity of Texas Southwestern Medical CenterCompletedMild to Moderate Skin Laxity on Cheek | Mild to Moderate Skin Laxity on Upper Neck | Mild to Moderate Subcutaneous Fat on Cheek | Mild to Moderate Subcutaneous Fat on Upper Neck
-
Helsinn Healthcare SACelerionCompletedHealthy Volunteers | Non-smokers | Moderate to Heavy SmokersUnited States
-
AstraZenecaRecruitingModerate-to-Severe AsthmaChina
-
University of California, San DiegoMayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women's Hospital and other collaboratorsRecruitingModerate to Severe AsthmaUnited States
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
AbbVie (prior sponsor, Abbott)University Health Network, TorontoCompletedModerate-to-severe Rheumatoid Arthritis
-
ImmuneMed, Inc.Not yet recruitingModerate to Severe Rheumatoid ArthritisNetherlands
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
Bracco Diagnostics, IncCompleted
-
The First Affiliated Hospital with Nanjing Medical...RecruitingModerate to Severe Allergic AsthmaChina
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
Raphaelle Jaquet-PilloudSwiss Foundation for the Health of Children and AdolescentsCompletedModerate to Severe BronchiolitisSwitzerland
-
Kyowa Kirin Co., Ltd.Active, not recruitingModerate to Severe Systemic SclerosisJapan
-
Synta Pharmaceuticals Corp.CompletedActive, Moderate to Severe Rheumatoid ArthritisNetherlands
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
Zhejiang Hisun Pharmaceutical Co. Ltd.CompletedModerate to Severe Active Rheumatoid ArthritisChina
-
Cytos Biotechnology AGTerminatedModerate to Severe Allergic AsthmaUnited States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
-
United States Army Research Institute of Environmental...CompletedResponse to Severe StressUnited States
-
San Diego Veterans Healthcare SystemCongressionally Directed Medical Research ProgramsCompletedPTSD With a History of Mild to Moderate TBIUnited States
-
Incyte CorporationWithdrawnModerate to Severe Ulcerative Colitis
-
Ganzhou Hemay Pharmaceutical Co., LtdRecruitingModerate to Severe Ulcerative ColitisChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingModerate to Severe Ulcerative ColitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Ulcerative ColitisUnited States, China, Pakistan, Ukraine
-
Medivation, Inc.PfizerTerminatedModerate to Severe AlzheimerChile, United Kingdom
-
Novartis PharmaceuticalsCompletedPatients With Moderate-to-severe COPD With Destroyed Lung by TuberculosisKorea, Republic of
-
Wenzhou Medical UniversityCompletedEfficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseModerate to Severe Dry Eye SyndromeChina
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom